PERIPARTUM CARDIOMYOPATHY: 10-YEAR CLINICAL FOLLOW-UP


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Background. Peripartum cardiomyopathy (PPCM) is one of the most severe forms of extragenital pathology, which often results in a fatal outcome. Actually, PPCM is variant of dilated cardiomyopathy, which develops in the last trimester of pregnancy and in the early postpartum period, leads to the development of congestive heart failure, and can be accompanied by thromboembolic complications and life-threatening rhythm disorders. Description of the clinical case. The article presents a 10-year clinical follow-up in the settings of the cardiological department of the female patient with PPCM, which managed to achieve stabilization of hemodynamics, reduction of the size of the heart cavities, increase in the myocardial contractility. The complexity of diagnosis and selection of adequate therapy are described. Conclusion. Each clinical experience in the management of patients with PPCM seems to be useful for developing a general concept of diagnostic and therapeutic approaches for this disease.

全文:

受限制的访问

作者简介

V. Sergeeva

Saratov State Medical University n.a. V.I. Razumovsky

Email: viktoriasergeeva@mail.ru
PhD, Teaching Assistant at the Department of Hospital Therapy of the Medical Faculty Saratov, Russia

S. Eliseeva

Regional Clinical Hospital

Saratov, Russia

E. Zhuravleva

Saratov State Medical University n.a. V.I. Razumovsky

Saratov, Russia

参考

  1. Сергеева В.А., Шмойлова А.С. Клинические проявления инфекционного миокардита у мужчин и женщин. Клиницист 2017;1(11):45-9.
  2. Bhakta IP, Biswas B.K., Banerjee B. Peripartum cardiomyopathy: review of the literature. Yonsei Med. J. 2007;48(5):731-47.
  3. Demakis J.G., Rahimtoola S.H., Sutton G.C., et al. Natural course of peripartum cardiomyopathy. Circulation. 1971;44:1053-61.
  4. Pearson G., Veille J., Rahimtoola S., Hsia J., et al. Peripartum cardiomyopathy:National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000;283(9):1183-88.
  5. Sliwa K., Hilfiker-Kleiner D., Petrie M.C., et al. Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Eur. J. Heart Fail. 2010; 12(8):767-78.
  6. Johnson-Coyle L., Jensen L., Sobey A. Peripartum Cardiomyopathy: Review and Practice Guidelines. Am. J. Crt Care. 2012;21(2):89-98.
  7. Барбараш О.Л., Артымук Н.В., Барбараш Н.А. Дилатационная кардиомиопатия в акушерской практике (обзор литературы и клинический случай). Проблемы женского здоровья. 2008;1(2):46-50.
  8. Sliwa K., Forster O., Libhaber E., et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur. Heart J. 2006;27(4):441-46.
  9. Melvin K.R., Richardson PJ., Olsen E.G., et al. Peripartum cardiomyopathy due to myocarditis. N. Engl. J. Med. 1982;30 7(12):731-34.
  10. Bhakta P., Biswas B.K., Banerjee B. Peripartum cardiomyopathy: review of the literature. Yonsei Med. J. 2007;48(5):731-47.
  11. Bultmann B.D., Klingel K., Nabauer M., et al. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am. J. Obstet. Gynecol. 2005;193(2):363-65.
  12. Rizeq M.N., Rickenbacher P.R., Fowler M.B., Billingham M.E. Incidence of myocarditis in peripartum cardiomyopathy. Am. J. Cardiol. 1994;74(5): 474-77.
  13. Ravikishore A.G., Kaul U.A., Sethi K.K., Khalilullah M. Peripartum cardiomyopathy: prognostic variables at initial evaluation. Int. J. Cardiol. 1991;32(3):377-80.
  14. Bhattacharyya A., Basra S.S., Sen P., Kar B. Peripartum Cardiomyopathy: A Review. Texas Heart Inst. J. 2012;39(1):8-16.
  15. Fett J.D., Sannon H., Thelisma E., et al. Recoveryfrom severe heart failure following peripartum cardiomyopathy. Int. J. Gynaecol. Obstet. 2009;104(2):125-27.
  16. Homans D.C. Peripartum cardiomyopathy. N. Engl. J. Med. 1985;312(22):1432-37.
  17. Amos A.M., Jaber WA, Russell S.D. Improved outcomes in peripartum cardiomyopathy with contemporary. Am. Heart J. 2006;152(3):509-13.
  18. Gentry M.B., Dias J.K., Luis A.,et al. African-American women have a higher risk for developing peripartum cardiomyopathy. J. Am. Coll. Cardiol. 2010;55(7):654-59.
  19. Elkayam U., Akhter M.W., Singh H., et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111(16): 2050-55.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2018
##common.cookie##